National Summary Report
Latest data from August 2023
HRSA uses the information collected to: help track health center capacity and the impact of COVID-19 on health center operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.
Health Center COVID-19 Survey Tool Questions
Health Center COVID-19 Survey Tool User Guide
Health Center Survey Data for COVID-19
Number of Look-Alike respondents = 61 (45% of all Look-Alike Health Centers)
Data represents information provided by health centers not funded through H80 grants from a single, specified monthly reporting date as indicated above. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Survey Results
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 3,558 |
| COVID-19 Vaccination Doses Administered |
320 |
| Percent of COVID-19 Vaccination Doses Administered to Racial and Ethnic Minorities | 89.43% |
| Percent of Health Centers Hosting Community-Based Events (Mobile Vans, Pop-Up Clinics, School-Based Sites, or Family Vaccination Clinics) | 14.75% |
| Number of Community-Based Events | 62 |
| Number of Collaboration Community-Based Events | 49 |
| Percent of Health Centers Administer Vaccines from Vaccine Program | 11.48% |
| Percent of Health Centers Distribute Test Kits from HRSA | 34.43% |
| Percent of Health Centers Distribute Oral Antiviral Medication from HRSA | 13.11% |
| COVID-19 Vaccination Doses Administered Through Health Center COVID-19 Vaccine Program | 320 |
| Percent of Health Center COVID-19 Vaccine Program Doses Administered to Racial and Ethnic Minorities | 89.43% |
| Percent of Health Center COVID-19 Vaccine Program Doses Administered to Special Populations | 16.88% |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 2,397 |
| Number of Patients Who Received COVID-19 Oral Antiviral Medication | 18 |
| Percent of COVID-19 Oral Antiviral Medications Given to Racial and Ethnic Minorities | 29.41% |
| Percent of COVID-19 Oral Antiviral Medications Given to Special Populations | 11.11% |
Date Last Reviewed: